[1] Wang BH, He MF, Chao A, Engelgau MM, Saraiya M, Wang LM, et al. Cervical cancer screening among adult women in China, 2010. Oncologist 2015;20(6):627 − 34. http://dx.doi.org/10.1634/theoncologist.2014-0303CrossRef
[2] Bao HL, Zhang L, Wang LM, Zhang M, Zhao ZP, Fang LW, et al. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med 2018;7(5):2089 − 100. http://dx.doi.org/10.1002/cam4.1321CrossRef
[3] International Agency for Research on Cancer. Cervix uteri source: globocan 2018. https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf. [2020-01-04].https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf
[4] World Health Organization. Draft: global strategy towards eliminating cervical cancer as a public health problem. https://www.who.int/docs/default-source/cervical-cancer/cerv-cancer-elimn-strategy-16dec-12pm.pdf. [2020-01-04].https://www.who.int/docs/default-source/cervical-cancer/cerv-cancer-elimn-strategy-16dec-12pm.pdf
[5] Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou XN, Chen R, et al. Report of cancer epidemiology in China, 2015. Chin J Oncol 2019;41(1):19 − 28. http://dx.doi.org/10.3760/cma.j.issn.0253-3766.2019.01.005 (In Chinese). CrossRef
[6] Li YC, Wang LM, Jiang Y, Zhang M, Wang LH. Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. Bull World Health Organ 2013;91(9):650 − 60. http://dx.doi.org/10.2471/BLT.13.117549CrossRef
[7] Guan YQ, Zhang M, Zhang X, Zhao ZP, Huang ZJ, Li C, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in the labor force population — China, 2015. China CDC Weekly 2020;2(10):147-55. http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2020.040.http://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2020.040
[8] Hu N, Jiang Y, Li YC, Chen YD. Data weighting methods for China Chronic Disease Surveillance (2010). Chin J Health Stat 2012;29(3): 424-6. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgwstj201203045. (In Chinese). http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgwstj201203045
[9] Bao HL, Wang LH, Wang LM, Fang LW, Zhang M, Zhao ZP, et al. Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013. Chin J Epidemiol 2018;39(2):208 − 12. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2018.02.014 (In Chinese). CrossRef
[10] Di JL. Opportunities and challenges in cervical cancer screening program in China: SWOT analysis for implementation of program. Qual Prim Care 2017;25(5):282-8. https://primarycare.imedpub.com/opportunities-and-challenges-in-cervical-cancerscreening-program-in-china-swot-analysis-forimplementation-of-program.php?aid=20761.https://primarycare.imedpub.com/opportunities-and-challenges-in-cervical-cancerscreening-program-in-china-swot-analysis-forimplementation-of-program.php?aid=20761